Spontaneous EBV-positive B cell line from rectal tumor: characterization, interaction with autologous tumor-infiltrating T lymphocytes, comparison with B lymphoma cell lines
Preprint
- 23 June 2025
- preprint
- Published by Springer Nature in Research Square
Abstract
Recent studies underscore herpesvirus-associated risks, especially HHV6 and Epstein–Barr virus (EBV), in CAR-T and tumor-infiltrating lymphocyte (TIL) therapies, partly due to ex vivo cell manipulation. EBV-driven B cell outgrowth can occur during TIL expansion, and EBV-transformed B cells may exert immunomodulatory functions, potentially impacting TIL therapy efficacy — areas that remain underexplored. Here, we characterized a spontaneously arising wild-type EBV-transformed B cell line, lcl_burn0214, derived from rectal cancer tumor tissue during ex vivo culture. The lcl_burn0214 cell line has undergone 70 passages and was confirmed as a monoclonal B cell line of patient origin via HLA genotyping, immunophenotyping (CD19, CD20), B cell receptor clonotype analysis. RNA-seq analysis comparing EBV-positive and -negative B lymphoma and lymphoblastoid cell lines revealed that lcl_burn0214’s gene expression closely resembles that of lymphoblastoid cells rather than malignant B lymphomas. In immunocompromised mice, lcl_burn0214 exhibited limited tumorigenicity. The cell line expressed immune checkpoint genes (CD274, CSF1, TNFSF4). Nevertheless, autologous TILs were negative for B cells and exhibited specific anti-EBV activity, as demonstrated by the interferon-gamma response in the ELISPOT assay during coculture with lcl_burn0214. Our findings underscore the importance of monitoring TIL products for EBV-positive B cell contamination during manufacturing to ensure safety and therapeutic efficacy.Keywords
All Related Versions
- Version 1, 2025-06-23, Research Square
- Published version: Scientific Reports, 15 (1).
This publication has 40 references indexed in Scilit:
- OX40/OX40 ligand and its role in precision immune oncologyCancer and Metastasis Reviews, 2024
- Reshaping tumor immune microenvironment by Epstein-Barr virus activation in the stroma of colorectal canceriScience, 2022
- Lymphomas associated with Epstein-Barr virus infection in 2020: Results from a large, unselected case series in FranceeClinicalMedicine, 2022
- Immunedeconv: An R Package for Unified Access to Computational Methods for Estimating Immune Cell Fractions from Bulk RNA-Sequencing Data2020
- CLASTR: The Cellosaurus STR similarity search tool ‐ A precious help for cell line authenticationInternational Journal of Cancer, 2019
- HLA‐HD: An accurate HLA typing algorithm for next‐generation sequencing dataHuman Mutation, 2017
- Introduction2016
- Patient-Derived Tumor Xenografts Are Susceptible to Formation of Human Lymphocytic TumorsNeoplasia, 2015
- B-lymphoblastoid cell lines from cancer patientsIn Vitro Cellular & Developmental Biology - Animal, 1998
- Tumorigenicity of EBV-carrying lymphoblastoid cell lines (LCLS): Distinctive grading in scid miceInternational Journal of Cancer, 1991